Many patients endure hours-long infusions because antibody doses can exceed 100 milliliters, far beyond subcutaneous limits ...

The company’s first-in-class and potential best-in-class therapeutics promise to be both effective and organ-protective and ...

Explore The Innovation Antibody and how organizational resistance can kill innovation from within, undermining growth, ...

Just-Evotec Biologics receives Gates Foundation grant for AI-driven optimization of monoclonal antibody developability for affordable access: Hamburg, Germany Saturday, January 10 ...

The collaboration builds on the internal strengths of Bayer in antibody design, synthesis and machine learning, complementing ...

Partnership has already generated high-quality, AI-ready data in less than three months MOUNTAIN VIEW, CA / ACCESS Newswire / January 8, 2026 / AbTherx today announced a therapeutic antibody discovery ...

Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

Orum Therapeutics (Orum or the Company) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Chad May, Ph.D., as Chief ...

As of Friday, January 09, Quanterix Corporation’s QTRX share price has surged by 18.97%, which has investors questioning if ...

Participants with prior infection were more likely than vaccine recipients to retain some detectable antibodies.

The market is defying broader economic headwinds through a structural pivot toward high-complexity outsourcing. While general ...

Just - Evotec Biologics will optimize monoclonal antibodies ("mAbs") and other biologic modalitiesInvestment enables ten new J.MD projects encompassing molecular optimization including, but not limite ...